On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Pharma Giant Merck & Co. Considering 600-Job IT Hub in Austin April 5, 2017 4 Biotechs Facing Do-or-Die Catalysts in December December 5, 2017 Aurora Diagnostics Inc. Acquires April 11, 2016
